The use of MR - less MNI based neuronavigation for 10 Hz rTMS depression therapy: electrophysiological and clinical implications\\r\\n

• Autorzy: Valiulis V. , Gerulskis G. , Dapsys K. , Valaviciute K. , Siurkute A. , Maciulis V.
• Języki publikacji: EN

Abstrakty

EN

Repetitive transcranial magnetic stimulation (rTMS) is a popular and effective treatment for drug resistant depression. However, there is considerable variability in clinical outcomes, in previous studies and between patients. Because of high requirements for the use of fMRI based neuronavigation, many practitioners of rTMS still choose to use a standard 5 cm rule for rTMS coil placement which leads to large variations in which brain regions are being stimulated. We decided to test the possibilities of a MNI based MR‑less neuronavigation system in rTMS depression treatment, by comparing the physiological effects and clinical outcomes of 3 distinct stimulation targets. Forty‑six patients (thirty‑three female, thirteen male) from the Republican Vilnius psychiatric hospital, all with drug resistant depressive disorder, participated in the study. All patients received high frequency (10 Hz) stimulation for 10 to 15 daily rTMS sessions. However, before the treatment they were randomly sorted into 3 groups according to stimulation target in MNI map: Group 1 received rTMS at point ‑40; 48; 35; Group 2 received rTMS at point ‑46; 45; 38; Group 3 received rTMS at point ‑38; 44; 26. Electroencephalography (EEG) recordings and clinical tests were obtained the day before the rTMS course and after the last session. There were some notable differences in physiological changes between the groups, with the largest EEG band spectral power increases found in Group 1 patients and the lowest in Group 2 patients. There was a significantly larger decrease of the Hamilton Depression Rating Scale (HAM-D) scores in the Group 3 (66.94%) compared to Group 1 (57.52%) and Group 2 (56.02%). This suggests it is possible to achieve higher clinical efficacy and less physiological impact on the brain when using different targets in a neuronavigated MNI based MR‑less rTMS system.

• Wydawca: -
• Czasopismo: Acta Neurobiologiae Experimentalis
• Rocznik: 2018
• Tom: 78
• Numer: 3
• Opis fizyczny: p.271-280,fig.,ref.

Twórcy

autor

Valiulis V.

• Republican Vilnius Psychiatric Hospital, Vilnius, Lithuania

autor

Gerulskis G.

• Republican Vilnius Psychiatric Hospital, Vilnius, Lithuania

autor

Dapsys K.

• Republican Vilnius Psychiatric Hospital, Vilnius, Lithuania
• Department of Neurobiology and Biophysics, Vilnius University, Vilnius, Lithuania

autor

Valaviciute K.

• Department of Neurobiology and Biophysics, Vilnius University, Vilnius, Lithuania

autor

Siurkute A.

• Republican Vilnius Psychiatric Hospital, Vilnius, Lithuania
• Psychiatry Clinic, Vilnius University, Vilnius, Lithuania

autor

Maciulis V.

• Republican Vilnius Psychiatric Hospital, Vilnius, Lithuania
• Psychiatry Clinic, Vilnius University, Vilnius, Lithuania

Bibliografia

• Ahdab R, Avache SS, Brugieres P, Goujon C, Lefaucher JP (2010) Compari‑ son of standard and navigated procedures of TMS coil positioning over motor, premotor and prefrontal targets in patients with chronic pain and depression. Neurophysiol Clin 40: 27–36.
• Assenza G, Pellegrino G, Tombini M, Di Pino G, Di Lazzaro V (2015) Wake‑ fulness delta waves increase after cortical plasticity induction. Clin Neu‑ rophysiol 126: 1221–1227.
• Avery DH, Holtzheimer PE III, Fawaz W (2006) A controlled study of repet‑ itive transcranial magnetic stimulation in medication‑resistant major depression. Biol Psychiatry 59: 187–194.
• Beck AT, Steer RA, Garbing MG (1988) Psychometric properties of the Beck Depression Inventory Twenty‑five years of evaluation. Clin Psych Review 8: 77–100.
• Bewernick B, Schlaepfer TE (2015) Update on neuromodulation for treat‑ ment‑resistant depression. F1000Res 4. pii: F1000 Faculty Rev‑1389.
• Blumberger DM, Maller JJ, Thomson  L, Mulsant BH, Raji TK, Maher  M, Brown PE, Downar J, Rodriguez FV, Fitzgerald PB, Daskalakis ZJ (2016) Unilateral and bilateral MRI‑targeted repetitive transcranial magnetic stimulation for treatment‑resistant depression: a  randomized con‑ trolled study. J Psychiatry Neurosci 41: E58–E66.
• Canali P, Sferrazza Papa G, Casali AG, Schiena G, Fecchio M, Pigorini A, Smeraldi E, Colombo C, Benedetti F (2014) Changes of cortical excit‑ ability as markers of antidepressant response in bipolar depression: preliminary data obtained by combining transcranial magnetic stim‑ ulation (TMS) and electroencephalography (EEG). Bipolar Disord 16: 809–819.
• Concerto C, Lanza G, Cantone M, Ferri R, Pennisi G, Bella R, Aguglia E (2015) Repetitive transcranial magnetic stimulation in patients with drug‑resis‑ tant major depression: A six‑month clinical follow‑up study. Int J Psychi‑ atry Clin Pract 19: 252–258.
• Deng Z, Lisanby SH, Peterchev AV (2013) Electric field depth‑focality tradeoff in transcranial magnetic stimulation: stimulation comparison of 50 coil designs. Brain Stimul 6: 1–13.
• Filipcic I, Milovac Z, Sucic S, Gajsak T, Simunovic Filipcic I, Ivezic E, Aljinovic V, Orgulan I, Zecevic Penic S, Bajic Z (2017) Efficacy, safety and tolerability of augmentative rTMS in treatment of major depressive dis‑ order (MDD): a prospective cohort study in Croatia. Psychiatria Danu‑ bina 29: 31–38.
• Fitzgerald PB, Brown TL, Marston NA (2003) Transcranial magnetic stimula‑ tion in the treatment of depression: a double‑blind, placebo controlled randomized trial. Arch Gen Psychiatry 60: 1002–1008.
• Fitzgerald PB, Benitez J, Castella A, Daskalakis ZJ, Timothy  L, Kulkarni J (2006) A  randomized, controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment‑resistant depression. Am J Psychiatry 63: 88–94.
• Fitzgerald PB, Hoy K, Daskalakis ZJ, Kulkarni J (2009a) A randomized trial of the anti‑depressant effects of low‑ and high‑frequency transcranial magnetic stimulation in treatment‑resistant depression. Depress Anx‑ iety 26: 229–235.
• Fitzgerald PB, Hoy K, McQueen S, Maller JJ, Herring S, Segrave R, Bailey M, Been G, Kulkarni J, Daskalakis ZJ (2009b) A randomized trial of rTMS tar‑ geted with MRI based neuro‑navigation in treatment‑resistant depres‑ sion. Neuropsychopharmacology 34: 1255–1262.
• Fox MD, Buckner RL, White MP, Greicius MD, Pasqual‑Leone A (2012a) Efficacy of TMS targets for depression is related to intrinsic func‑ tional connectivity with the subgenual cingulate. Biol Psychiatry 72: 595–603.
• Fox MD, Halko MA, Eldaief MC, Pascual‑Leone A (2012b) Measuring and manipulating brain connectivity with resting state functional connectiv‑ ity magnetic resonance imaging (fcMRI) and transcranial magnetic stim‑ ulation (TMS). Neuroimage 62: 2232–2243.
• Fox MD, Liu H, Pasqual‑Leone A (2013) Identification of reproducible indi‑ vidualized target for treatment of depression with TMS based on intrin‑ sic connectivity. Neuroimage 66: 151–160.
• Funk AP, George MS (2008) Prefrontal EEG asymmetry as a potential bio‑ marker of antidepressant treatment response with transcranial mag‑ netic stimulation (TMS): a case series. Clin EEG Neurosci 39: 125–130.
• George MS, Taylor JJ, Short EB (2013) The expanding evidence base for rTMS treatment of depression. Curr Opin Psychiatry 26: 13–18.
• Griškova I, Rukšėnas O, Dapšys K, Herpertz S, Hoppner J (2007) The effects of 10  Hz repetitive transcranial magnetic stimulation on resting EEG power spectrum in healthy subjects. Neurosci Lett 419: 162–167.
• Henriques JB, Davidson RJ (1991) Left frontal hypoactivation in depression. J Abnormal Psychol 100: 535–545.
• Herwig U, Padberg F, Unger J, Spitzer M, Schonfeldt‑Lecuona C (2001) Tran‑ scranial magnetic stimulation in therapy studies: examination of the re‑ liability of standard coil positioning by neuronavigation. Biol Psychiatry 50: 58–61.
• Huang YZ, Rothwell JC, Chen RS, Lu CS, Chuang WL (2011) The theoretical model of theta burst form of repetitive transcranial magnetic stimula‑ tion. Clin Neurophysiol 122: 1011–1018.
• Jha S, Chadda RK, Kumar N, Bal CS (2016) Brain SPECT guided repetitive transcranial magnetic stimulation (rTMS) in treatment resistant major depressive disorder. Asian J Psychiatr 21: 1–6.
• Kito S, Hasegawa T, Koga Y (2011) Neuroanatomical correlates of thera‑ peutic efficacy of low‑frequency right prefrontal transcranial magnetic stimulation in treatment‑resistant depression. Psychiatry Clin Neurosci 65: 175–182.
• Kito S, Hasegawa T, Takamiya A, Noda T, Nakagome K, Higuchi T, Koga Y (2016) Transcranial magnetic stimulation modulates resting EEG func‑ tional connectivity between the left dorsolateral prefrontal cortex and limbic regions in medicated patients with treatment‑resistant depres‑ sion. J Neuropsychiatry Clin Neurosci 29: 155–159.
• Kobayashi B, Cook IA, Hunter AM, Minzenberg MJ, Krantz DE, Leuchter AF (2017) Can neurophysiologic measures serve as biomarkers for the efficacy of repetitive transcranial magnetic stimulation treatment of major depressive disorder? Int Rev Psychiatry 29: 98–114.
• Lioumis P, Kicić D, Savolainen P, Mäkelä JP, Kähkönen S (2009) Re‑ producibility of TMS‑Evoked EEG responses. Hum Brain Mapp 30: 1387–1396.
• Loo C, Sachdev P, Elsayed H, McDarmont B, Mitchell P, Wilkinson  M, Parker G, Gandevia S (2001) Effects of a 2‑ to 4‑week course of repetitive transcranial magnetic stimulation (rTMS) on neuropsychologic function‑ ing, electroencephalogram, and auditory threshold in depressed pa‑ tients. Biol Psychiatry 49: 615–623.
• Lubar JF, Congedo M, Askew JH (2003) Low‑resolution electromagnetic to‑ mography (LORETA) of cerebral activity in chronic depressive disorder. Int J Psychopathol 49: 175–185.
• Luber BM, Davis S, Bernhardt E, Neacsiu A, Kwapil  L, Lisanby SH, Strauman TJ (2017) Using neuroimaging to individualize TMS treatment for depression: Toward a new paradigm for imaging‑guided interven‑ tion. Neuroimage 148: 1–7.
• Mayberg HS, Brannan SK, Tekell JL, Silva JA, Mahurin RK, McGinnis S, Jerabek PA (2000) Regional metabolic effects of fluoxetine in major de‑ pression: serial changes and relationship to clinical response. Biol Psy‑ chiatry 48: 830–843.
• Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C, Schwalb JM, Kennedy SH (2005) Deep brain stimulation for treat‑ ment‑resistant depression. Neuron 45: 651–660.
• Melnikova TS, Tsukarzi EE, Kovalev AV, Mosolov SN (2015) EEG spectral characteristics in resistant depression patients on transcranial magnetic stimulation treatment. Zh Nevrol Psikhiatr Im S S Korsakova 115: 35–41.
• Mir‑Moghtadaei A, Caballero R, Fried P, Fox MD, Lee K, Giacobbe P, Daskalakis ZJ, Blumberger DM, Downar J (2015) Concordance between BeamF3 and MRI-neuronavigated target sites for repetitive transcrani‑ al magnetic stimulation of the left dorsolateral prefrontal cortex. Brain Stimul 8: 965–973.
• Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Brit. J Psychiat 134: 982–989.
• Morvai S, Nagy A, Kovacs A, More CE, Berecz R, Frecska E (2016) Unan‑ swered questions in the transcranial magnetic stimulation treatment of patients with depression. Ideggyogy Sz 69: 4–11. Noh NA (2016) Exploring cortical plasticity and oscillatory brain dynamics via transcranial magnetic stimulation and resting‑state electroencepha‑ logram. Malays J Med Sci 23: 5–16.
• O’Reardon JP, Solvason HB, Janicak PG, Sampson S, Isenberg KE, Nahas Z, McDonald WM, Avery D, Fitzgerald PB, Loo C, Demitrack MA, George MS, Sackeim HA (2007) Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a  multisite randomized controlled trial. Biol Psychiatry 62: 1208–1216.
• Padberg F, George MS (2009) Repetitive transcranial magnetic stimulation of the prefrontal cortex in depression. Exp Neurol 219: 2–13.
• Paus T, Barrett J (2004) Transcranial magnetic stimulation (TMS) of the hu‑ man frontal cortex: implications for repetitive TMS treatment of depres‑ sion. J Psychiatry Neurosci 29: 268–279.
• Pommier B, Vassal F, Boutet C, Jeannin S, Peyron R, Faillenot I (2017) Easy methods to make the neuronavigated targeting of DLPFC accurate and routinely accessible for rTMS. Neurophysiol Clin 47: 35–46.
• Pulcu E, Zahn R, Moll J, Trotter PD, Thomas EJ, Juhasz G, Deakin JFW, Anderson IM, Sahakian BJ, Elliott R (2014) Enhanched subgenual cingu‑ late response to altruistic decisions in remitted major depressive disor‑ der. Neuroimage Clin 4: 701–710.
• Sackeim HA, Luber B, Katzman GP, Moeller JR, Prudic J, Devenand DP, Nobler MS (1996) The effects of electroconvulsive therapy on quanti‑ tative electroencephalograms. Relationships to clinical outcome. Arch Gen Psychiatry 53: 814–824.
• Sale MV, Mattingley JB, Zalesky A, Cocchi  L (2015) Imaging human brain networks to improve the clinical efficacy of non‑invasive brain stimula‑ tion. Neurosci Biobehav Rev 57: 187–198.
• Sehatzedeh Sh, Tu HA, Palimaka S, Yap B, O’Reilly D, Bowen J (2016) Re‑ petitive transcranial magnetic stimulation for treatment‑resistant de‑ pression: a systematic review and meta‑analysis of randomized con‑ trolled trials. Ont Health Technol Assess Ser 16: 1–66.
• Silverstein WK, Noda Y, Barr MS, Vila‑Rodriguez F, Rajji TK, Fitzgerald PB, Downar J, Mulsant BH, Vigod S, Daskalakis ZJ, Blumberger DM (2015) Neurobiological predictors of response to dorsolateral prefrontal cortex repetitive transcranial magnetic stimulation in depression: a systematic review. Depress Anxiety 32: 871891.
• Spronk D, Arns M, Bootsma A, van Ruth R, Fitzgerald PB (2008) Long‑term effects of left frontal kTMS on EEG and ERPs in patients with depression. Clin EEG Neurosci 39: 118–124.
• Tarhan N, Sayar FG, Tan O, Kagan G (2012) Efficacy of high‑frequency re‑ petitive transcranial magnetic stimulation in treatment‑resistant de‑ pression. Clin EEG Neurosci 43: 279–284.
• Teneback CC, Nahas Z, Speer AM, Molloy  M, Stallings LE, Spicer KM, Risch SC, George MS (1999) Changes in prefrontal cortex and paralimbic activity in depression following two weeks of daily left prefrontal TMS. J Neuropsychiatry Clin Neurosci 11: 426–435.
• Teng S, Guo Z, Peng H, Xing G, Chen H, He B, McClure MA, Mu Q (2017) High‑frequency repetitive transcranial magnetic stimulation over the left DLPFC for major depression: Session‑dependent efficacy: A me‑ ta‑analysis. Eur Psychiatry 41: 75–84.
• Thielscher A, Kammer T (2004) Electric field properties of two commercial figure‑8 coils in TMS: calculation of focality and efficiency. Clin Neuro‑ physiol 115: 1697–1708.
• Thut G, Pascual‑Leone A (2010) A review of combined TMS‑EEG studies to characterize lasting effects of repetitive TMS and assess their usefulness in cognitive and clinical neuroscience. Brain Topogr 22: 219–232.
• Trivedi MH, Fava M, Wisniewski SR (2006) Medication augmentations after the failure of SSRIs for depression. N Engl J Med 354: 1243–1252.
• Valiulis V, Gerulskis G, Dapšys K, Vištartaitė G, Šiurkutė A, Mačiulis V (2012) Electrophysiological differences between high and low frequency kTMS protocols in depression treatment. Acta Neurobiol Exp 72: 283–295.
• Valiulis V (2014) The effect of transcranial magnetic stimulation on brain bioelectrical activity. Summary of doctoral dissertation. Vilnius Univer‑ sity press. van der Vinne N, Vollebregt MA, van Putten MJAM, Arns M (2017) Frontal alpha asymmetry as a diagnostic marker in depression: Fact or fiction? A meta‑analysis. Neuroimage Clin 16: 79–87.
• Widge AS, Avery DH, Zarkowski P (2013) Baseline and treatment‑emergent EEG biomarkers of antidepressant medication response do not predict response to repetitive transcranial magnetic stimulation. Brain Stimul 6: 929–931.
• Williams JBW (1989) A structured interview guide for the Hamilton Depres‑ sion Rating Score. Arch Gen Psychiatry 45: 742–747.
• Zyss T, Rachel  W, Datka  W, Dudek D, Zieba A, Gorczyca P, Hese RT, Szwajca K, Piekoszewski W (2015) Transcranial magnetic stimulation in psychiatric therapy (in Polish). Przegl Lek 72: 371–375.

Identyfikatory

DOI

10.21307/ane‑2018‑025